Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
about
Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial.Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and its kidney clearance: post-hoc analyses of four clinical trials.The renoprotective effect and safety of a DPP-4 inhibitor, sitagliptin, at a small dose in type 2 diabetic patients with a renal dysfunction when changed from other DPP-4 inhibitors: REAL trial.The effect of liraglutide on renal function: A randomized clinical trial.The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin.
P2860
Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Renal Effects of DPP-4 Inhibit ...... ind, Placebo-Controlled Trial.
@en
type
label
Renal Effects of DPP-4 Inhibit ...... ind, Placebo-Controlled Trial.
@en
prefLabel
Renal Effects of DPP-4 Inhibit ...... ind, Placebo-Controlled Trial.
@en
P2093
P50
P356
P1433
P1476
Renal Effects of DPP-4 Inhibit ...... ind, Placebo-Controlled Trial.
@en
P2093
A H Jan Danser
Daniël H van Raalte
Jaap A Joles
Lennart Tonneijck
Mark H H Kramer
Michaela Diamant
Piet M Ter Wee
P304
P356
10.2337/DC16-1371
P407
P577
2016-09-01T00:00:00Z